Other OTC Pharmaceuticals (Pharmacies) - Eastern Asia

  • Eastern Asia
  • Revenue in the Other OTC Pharmaceuticals market is projected to reach US$5.39bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 1.67%, resulting in a market volume of US$5.76bn by 2028.
  • In global comparison, most revenue will be generated in the United States (US$4,981.00m in 2024).
  • In relation to total population figures, per person revenues of US$3.30 are generated in 2024.

Key regions: United Kingdom, Canada, France, Europe, Japan

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals (Pharmacies) market in Eastern Asia is experiencing significant growth and development due to various factors. Customer preferences in the region play a crucial role in driving the market. Eastern Asian customers have a strong preference for self-medication and over-the-counter (OTC) pharmaceutical products. This preference is driven by several factors, including convenience, cost-effectiveness, and a cultural belief in the efficacy of traditional remedies. Customers in this region often rely on OTC products to treat common ailments and minor health issues, such as colds, headaches, and digestive problems. Additionally, the growing middle-class population in Eastern Asia has increased disposable income, leading to higher spending on healthcare products, including OTC pharmaceuticals. Several trends are shaping the Other OTC Pharmaceuticals (Pharmacies) market in Eastern Asia. One prominent trend is the increasing popularity of natural and herbal remedies. Eastern Asian customers have a long-standing tradition of using traditional medicine, such as herbal remedies, acupuncture, and traditional Chinese medicine. This trend has led to a rising demand for OTC pharmaceutical products that are derived from natural ingredients and have minimal side effects. Manufacturers and retailers in the region are responding to this trend by introducing a wide range of natural and herbal OTC products to cater to the growing demand. Another trend in the market is the growing emphasis on product innovation and differentiation. With the increasing competition in the OTC pharmaceutical market, companies are constantly striving to develop unique and innovative products to attract customers. This includes the introduction of new formulations, such as chewable tablets, effervescent tablets, and quick-dissolving tablets, which offer convenience and ease of use. Companies are also investing in research and development to develop OTC products that target specific health conditions or address niche markets. Local special circumstances in Eastern Asia also contribute to the development of the Other OTC Pharmaceuticals (Pharmacies) market. For example, the region has a large aging population, which is driving the demand for OTC products related to age-related health issues, such as joint pain, insomnia, and memory enhancement. Additionally, the high population density in many Eastern Asian countries, such as China and Japan, creates a demand for easily accessible healthcare products, leading to the proliferation of pharmacies and OTC retailers. Underlying macroeconomic factors, such as economic growth and increasing healthcare expenditure, also play a role in the development of the market. Eastern Asia has experienced rapid economic growth in recent years, leading to higher disposable incomes and increased healthcare spending. As a result, customers in the region are more willing to spend on OTC pharmaceutical products to maintain their health and well-being. In conclusion, the Other OTC Pharmaceuticals (Pharmacies) market in Eastern Asia is developing due to customer preferences for self-medication, the popularity of natural and herbal remedies, product innovation, local special circumstances, and underlying macroeconomic factors. These factors are driving the growth and expansion of the market in the region.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)